Jagsonpal Pharmaceuticals standalone net profit rises 707.83% in the December 2024 quarter
Sales rise 56.74% to Rs 74.03 crore
Net profit of Jagsonpal Pharmaceuticals rose 707.83% to Rs 31.99 crore in the quarter ended December 2024 as against Rs 3.96 crore during the previous quarter ended December 2023. Sales rose 56.74% to Rs 74.03 crore in the quarter ended December 2024 as against Rs 47.23 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales74.0347.23 57 OPM %21.387.18 -PBDT17.905.68 215 PBT15.495.27 194 NP31.993.96 708Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 23 2025 | 7:31 AM IST